Updates in the Management of Small-Cell Lung Cancer in the Second-Line and Beyond

home / scientific-interchange-and-workshop / updates-in-the-management-of-small-cell-lung-cancer-in-the-second-line-and-beyond
Fred R. Hirsch, MD, PhD

EP. 1: Dr. Hirsch on Diagnosing and Managing Metastatic SCLC

January 16th 2023

Fred R. Hirsch, MD, PhD, discusses the rarity of diagnosing small cell lung cancer early in the disease course, unmet needs in SCLC screening, the importance of ECOG performance score when considering patients for clinical trials, and factors influencing hospice care decisions in patients with SCLC.

Nagashree Seetharamu, MD, MBBS

EP. 2: Dr. Seetharamu on Individualized Care in SCLC

January 16th 2023

Nagashree Seetharamu, MD, MBBS, discusses interpreting the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology and deciding when to initiate hospice care in patients with small cell lung cancer.

Balazs Halmos, MD

EP. 3: Dr. Halmos on the Safety and Efficacy of Lurbinectedin in Second-line SCLC

January 26th 2023

Balazs Halmos, MD, discusses the safety and efficacy of lurbinectedin in the second-line setting for patients with small cell lung cancer.

Updates in the Management of Small Cell Lung Cancer in the Second Line and Beyond

EP. 4: Updates in the Management of Small Cell Lung Cancer in the Second Line and Beyond

February 17th 2023